Lmr Partners LLP Pfizer Inc Put Options Transaction History

Lmr Partners LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 07, 2024	BUY	$27.7 - $31.39 $3.46 Million - $3.92 Million	125,000 New	125,000 $3.62 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $1.6 Million - $1.88 Million	-50,000 Reduced 9.12%	498,300 $16.5 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $19.8 Million - $22.9 Million	548,300 New	548,300 $20.1 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $57.1 Million - $67.7 Million	-1,227,100 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $56.1 Million - $69.6 Million	1,227,100 New	1,227,100 $63.5 Million

3,258

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.